As of 12:35pm ET
| +0.095 / +1.02%|
The 3 analysts offering 12-month price forecasts for Fennec Pharmaceuticals Inc have a median target of 18.00, with a high estimate of 22.00 and a low estimate of 17.00. The median estimate represents a +91.59% increase from the last price of 9.40.
The current consensus among 3 polled investment analysts is to Buy stock in Fennec Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.